NCT00963833 Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis Status COMPLETED Phase N/A
NCT00958009 The Multicenter, Open-label, Single-use Autoinjector Convenience Study Status COMPLETED Phase PHASE3
NCT00954421 Use of Two Deep Brain Stimulation (DBS) Electrodes to Treat Post-Traumatic Tremor Status COMPLETED Phase NA
NCT00947895 Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone Status TERMINATED Phase PHASE2/PHASE3
NCT00947232 Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCI Status COMPLETED Phase NA
NCT00944190 TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS) Status COMPLETED Phase NA
NCT00942591 Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b Status COMPLETED Phase PHASE2
NCT00942214 Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment Status COMPLETED Phase PHASE4
NCT00940719 Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS) Status COMPLETED Phase NA
NCT00938366 Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects Status COMPLETED Phase PHASE1
NCT00937677 Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study Status COMPLETED Phase N/A
NCT00937157 Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) Status COMPLETED Phase NA
NCT00928967 Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients Status COMPLETED Phase N/A
NCT00922831 Progression of Cognitive and Physical Symptoms in Multiple Sclerosis Status WITHDRAWN Phase N/A
NCT00915577 Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe Status COMPLETED Phase PHASE3
NCT00914290 A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00913666 Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers Status COMPLETED Phase PHASE4
NCT00913510 Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction Status TERMINATED Phase NA